Meritking Giriş: Meritking Spor BahisleriMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Güvenilir Mi, Meritking Bonus Ve KampanyalarMarsbahis Giriş: Marsbahis Giriş Adresi, Marsbahis Mobilden Giriş 2026Mavibet Giriş: Mavibet Spor Bahisleri, Mavibet Casino Ve Slot OyunlarıMeritking Giriş: Meritking Spor BahisleriMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Giriş Adresi, Meritking Casino Ve Slot OyunlarıMarsbahis Giriş: Marsbahis Güvenilir Mi, Marsbahis Spor BahisleriMavibet Giriş: Mavibet Para Yatırma Ve Çekme İşlemleriMeritking Giriş: Meritking Spor BahisleriMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Mobilden Giriş 2026Meritking Giriş: Meritking Para Yatırma Ve Çekme İşlemleriMarsbahis Giriş: Marsbahis Spor BahisleriMavibet Giriş: Mavibet Giriş Adresi, Mavibet Güvenilir MiMeritking Giriş: Meritking Giriş Adresi, Meritking Casino Ve Slot OyunlarıMarsbahis Giriş: Marsbahis Güvenilir Mi, Marsbahis Spor BahisleriMavibet Giriş: Mavibet Para Yatırma Ve Çekme İşlemleriMeritking Giriş: Meritking Spor Bahisleri, Meritking Casino Ve Slot OyunlarıMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Canlı Destek Ve İletişimMarsbahis Giriş: Marsbahis Casino Ve Slot OyunlarıMavibet Giriş: Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Spor Bahisleri, Meritking Giriş AdresiMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir MiMeritking Giriş: Meritking Canlı Destek Ve İletişimMarsbahis Giriş: Marsbahis Casino Ve Slot Oyunları, Marsbahis Spor BahisleriMavibet Giriş: Mavibet Bonus Ve Kampanyalar, Mavibet Giriş AdresiMeritking Giriş: Meritking Güvenilir Mi, Meritking Bonus Ve KampanyalarMarsbahis Giriş: Marsbahis Giriş Adresi, Marsbahis Mobilden Giriş 2026Mavibet Giriş: Mavibet Spor BahisleriMeritking Giriş: Meritking Giriş Adresi, Meritking Mobilden Giriş 2026Marsbahis Giriş: Marsbahis Güvenilir Mi, Marsbahis Bonus Ve KampanyalarMavibet Giriş: Mavibet Para Yatırma Ve Çekme İşlemleriMeritking Giriş: Meritking Para Yatırma Ve Çekme İşlemleriMarsbahis Giriş: Marsbahis Spor Bahisleri, Marsbahis Casino Ve Slot OyunlarıMavibet Giriş: Mavibet Giriş Adresi, Mavibet Mobilden Giriş 2026Meritking Giriş: Meritking Canlı Destek Ve İletişimMarsbahis Giriş: Marsbahis Casino Ve Slot OyunlarıMavibet Giriş: Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Giriş AdresiMarsbahis Giriş: Marsbahis Güvenilir MiMavibet Giriş: Mavibet Para Yatırma Ve Çekme İşlemleriMeritking Giriş: Meritking Güvenilir Mi, Meritking Giriş AdresiMarsbahis Giriş: Marsbahis Giriş Adresi, Marsbahis Bonus Ve KampanyalarMavibet Giriş: Mavibet Spor Bahisleri, Mavibet Casino Ve Slot OyunlarıMeritking Giriş: Meritking Spor Bahisleri, Meritking Casino Ve Slot OyunlarıMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Spor Bahisleri, Meritking Casino Ve Slot OyunlarıMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Bonus Ve KampanyalarMeritking Giriş: Meritking Güvenilir Mi, Meritking Bonus Ve KampanyalarMarsbahis Giriş: Marsbahis Giriş Adresi, Marsbahis Mobilden Giriş 2026Mavibet Giriş: Mavibet Spor BahislerikalitebetextrabetMeritking Giriş: Meritking Spor Bahisleri, Meritking Casino Ve Slot OyunlarıMarsbahis Giriş: Marsbahis Para Yatırma Ve Çekme İşlemleriMavibet Giriş: Mavibet Güvenilir Mi, Mavibet Bonus Ve KampanyalarAntalya EscortBursa Escort Bayanistanbul çilingirAntalya Escort BayanHasta YatağıAntalya Escort bayanAntalya Escort BayanMeritking Giriş: Meritking Güvenilir Mi, Meritking Bonus Ve KampanyalarMarsbahis Giriş: Marsbahis Giriş Adresi, Marsbahis Mobilden Giriş 2026Mavibet Giriş: Mavibet Spor Bahisleri, Mavibet Casino Ve Slot OyunlarıBursa Escort BayanEdirne Escort Bayanİzmir Escort BayanBursa Escort BayanAntalya Escort BayanbetroybetroyAntalya Masaj spa Sauna adresi buradabetroyhacklinkhacklink satın alhacklink albacklinkbacklink albacklink satın alhacklink kaufenhacklink buyкупить хак-ссылкиشراء روابط مخترقةcomprar enlaces de spam购买外链हैकलिंक खरीदेंacheter des liens de référencementহ্যাকলিংক কিনুনcomprar links de spambeli hacklinkbursa escortbetroybetroybetroygüvenilir bahis sitelerideneme bonusu veren sitelercasino sitelerimaxwingrandpashabetMore informationradissonbetdedebetgrandpashabetgrandpashabetgrandpashabetgrandpashabet girişgrandpashabetgrandpashabet girişgrandpashabetgrandpashabet girişgrandpashabetgrandpashabet girişGrandpashabetGrandpashabet girişGrandpashabet güncel girişVisit Websitecasibommarsbahisultrabetultrabet girişgalabetgalabet girişromabetromabet girişeditörbeteditörbet girişenjoybetenjoybet girişkulisbetkulisbet girişpadişahbetpadişahbet girişmarsbahismarsbahis girişefesbetefesbet giriş

Most eligible teens miss out on advanced obesity treatments

Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago published in JAMA Pediatrics.

The motivation behind our paper was to look at the relationship between two exciting developments in the treatment of obesity in adolescence. The first is long-term evidence for the safety and efficacy of bariatric surgery in adolescents, and the other is FDA approval of GLP-1s in this age group.”


John B. Rode, MD, MS, first author, a fourth-year resident physician at Lurie Children’s

In the current study, investigators analyzed electronic health records from more than 1.4 million U.S. adolescents who met guideline-based eligibility criteria for metabolic and bariatric surgery between 2017 and 2025. They found that use of GLP-1s, including semaglutide and liraglutide, increased dramatically during the study period, while rates of bariatric surgery began to decline following the approval of semaglutide for adolescent obesity in late 2022.

The investigators found that bariatric surgery use among eligible adolescents increased steadily from 2017 through 2022, reaching a peak of 189 procedures per 100,000 eligible teens.

“Our study found that while bariatric surgery use increased between 2017 and 2022, it subsequently decreased about 29 percent through the end of 2025,” Dr. Rode said. “This decline coincided with the FDA approval of semaglutide for adolescents aged 12 or older with obesity.”

At the same time, prescriptions for GLP-1 medications increased sharply. Overall prescribing rates rose from 301 prescriptions per 100,000 eligible adolescents in early 2017 to 10,676 per 100,000 by the end of 2025, a 35-fold increase. Rates were highest among adolescents with the most severe obesity.

However, among the 1.4 million adolescents who qualified for bariatric surgery, less than 1 percent underwent surgery during the study period, while 4.6 percent received at least one GLP-1 prescription. By the fourth quarter of 2025, more than 1.29 million eligible adolescents, representing 90.4 percent of the study population, had received neither treatment.

“We found that nine out of 10 adolescents who qualified for bariatric surgery received neither treatment throughout the whole study period between 2017 and 2025,” Dr. Rode said. “Our findings suggest that even though we’ve developed safe and effective treatments for obesity in adolescents, the data indicate that those who qualify likely don’t have access to these treatments.”

Dr. Rode and his collaborators also identified disparities in access to GLP-1 medications. By late 2025, privately insured adolescents were prescribed GLP-1 drugs at rates 2.4 times higher than uninsured or self-pay patients and modestly higher than publicly insured patients. Bariatric surgery rates, however, were similar across insurance groups.

The findings raise concerns that newer obesity medications could be widening existing inequities in care, Dr. Rode said.

“As rates of childhood obesity continue to rise, further research is needed to understand how GLP-1s might change the landscape of obesity care, including the potential complementary role with metabolic and bariatric surgery,” Dr. Rode said. “Most importantly, further research is necessary to understand the reasons behind this lack of access to evidence-based treatments, to make sure that patients receive the care that they need.”

Justin Ryder, PhD, Vice Chair of Research for the Department of Surgery at Lurie Children’s and Associate Professor of Surgery and Pediatrics at Northwestern University Feinberg School of Medicine, was the senior author on the study.

The study was supported by the National Cancer Institute under award T32CA247801.

Source:

Journal reference:

Rode, J. B., et al. (2026). Metabolic and bariatric surgery and GLP-1 receptor agonist use among adolescents. JAMA Pediatrics. DOI: 10.1001/jamapediatrics.2026.4584. https://jamanetwork.com/journals/jamapediatrics/article-abstract/2854870

Team Health Accessible
Author

Team Health Accessible

Health & Wellness Editorial Team

HealthAccessible editorial team delivers trusted, accessible, and evidence-based health information for everyone.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share